The obesity treatment industry is expanding rapidly, creating a significant opportunity for investors. Companies like Novo Nordisk and Eli Lilly have taken the lead in addressing the growing global obesity epidemic with groundbreaking drugs like Ozempic, Wegovy, Zepbound, and Mounjaro. These treatments have driven massive revenue growth, and analysts expect this trend to accelerate as…

Continue Reading